COMPARATIVE PREDICTIVE VALUES OF URINARY CYTOLOGY, URINARY BLADDER CANCER ANTIGEN, CYFRA 21-1 AND NMP22 FOR EVALUATING SYMPTOMATIC PATIENTS AT RISK FOR BLADDER CANCER
- 1 May 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 165 (5) , 1462-1467
- https://doi.org/10.1016/s0022-5347(05)66328-8
Abstract
Purpose: We study the potential diagnostic use of urinary bladder cancer antigen, CYFRA 21-1 and NMP22 * *Matritech, Cambridge, Massachusetts.; for evaluating symptomatic patients who present with ...Keywords
This publication has 29 references indexed in Scilit:
- COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 TO DETECT BLADDER CANCERJournal of Urology, 1999
- Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladderBJU International, 1999
- INITIAL EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE NEW URINARY BLADDER CANCER ANTIGEN TEST AS A TUMOR MARKER FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 1999
- Evaluation of Urinary Level of NMP22 as a Diagnostic Marker for Stage pTa-pT1 Bladder Cancer: Comparison with Urinary Cytology and BTA TestEuropean Urology, 1999
- Initial Evaluation of Cyfra 21-1 Diagnostic Performances as a Urinary Marker in Bladder Transitional Cell CarcinomaJournal of Urology, 1997
- Urinary Nuclear Matrix Protein as a Marker for Transitional Cell Carcinoma of the Urinary TractJournal of Urology, 1996
- Superficial bladder cancer: for how long should a tumour‐free patient have check cystoscopies?British Journal of Urology, 1995
- The biochemistry of CYFRA 21—1 and other cytokeratin-testsScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Analytical requirements and standardization of CA 15—3Scandinavian Journal of Clinical and Laboratory Investigation, 1995
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990